Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 3 April 2008. doi:10.1136/ard.2008.088245
Annals of the Rheumatic Diseases 2009;68:384-390
Copyright © 2009 BMJ Publishing Group Ltd & European League Against Rheumatism.

CLINICAL AND EPIDEMIOLOGICAL RESEARCH

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

M L Hetland1, B Ejbjerg1,2, K Hørslev-Petersen3, S Jacobsen4, A Vestergaard5, A G Jurik6, K Stengaard-Pedersen7, P Junker8, T Lottenburger3, I Hansen7, L S Andersen3, U Tarp7, H Skjødt1, J K Pedersen3, O Majgaard1, A J Svendsen3, T Ellingsen7, H Lindegaard8, A F Christensen8, J Vallø9, T Torfing10, E Narvestad5, H S Thomsen11, M Østergaard3, and the CIMESTRA study group

1 Department of Rheumatology, Copenhagen University Hospital, Hvidovre, Denmark
2 Department of Rheumatology, Copenhagen University Hospital, Herlev, Denmark
3 Department of Rheumatology, Rheumatism Hospital, University of Southern Denmark, Gråsten, Denmark
4 Department of Rheumatology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
5 Department of Radiology, Copenhagen University Hospital, Hvidovre, Denmark
6 Department of Radiology, Århus University Hospital, Århus, Denmark
7 Department of Rheumatology, Århus University Hospital, Århus, Denmark
8 Department of Rheumatology, Odense University Hospital, Odense, Denmark
9 Department of Radiology, Aabenraa Sygehus, Aabenraa, Denmark
10 Department of Radiology, Odense University Hospital, Odense, Denmark
11 Department of Radiology, Copenhagen University Hospital, Herlev, Denmark

Dr K Hørslev-Petersen, Rheumatism Hospital, University of Southern Denmark, Toldbodgade 3, DK-6300 Gråsten, Denmark; khorslevpetersen{at}gigtforeningen.dk

Objective: To identify predictors of radiographic progression in a 2-year randomised, double-blind, clinical study (CIMESTRA) of patients with early rheumatoid arthritis (RA).

Methods: Patients with early RA (n = 130) were treated with methotrexate, intra-articular betamethasone and ciclosporin/placebo-ciclosporin. Baseline magnetic resonance imaging (MRI) of the wrist (wrist-only group, n = 130) or MRI of wrist and metacarpophalangeal (MCP) joints (wrist+MCP group, n = 89) (OMERACT RAMRIS), x-ray examination of hands, wrists and forefeet (Sharp/van der Heijde Score (TSS)), Disease Activity Score (DAS28), anti-cyclic citrullinated peptide antibodies (anti-CCP), HLA-DRB1-shared epitope (SE) and smoking status were assessed. Multiple regression analysis was performed with delta-TSS (0–2 years) as dependent variable and baseline DAS28, TSS, MRI bone oedema score, MRI synovitis score, MRI erosion score, anti-CCP, smoking, SE, age and gender as explanatory variables.

Results: Baseline values: median DAS28 5.6 (range 2.4–8.0); anti-CCP positive 61%; radiographic erosions 56%. At 2 years: DAS28 2.0 (0.5–5.7), in DAS remission: 56%, radiographic progression 26% (wrist+MCP group, similar for wrist-only group). MRI bone oedema score was the only independent predictor of delta-TSS (wrist+MCP group: coefficient = 0.75 (95% CI 0.55 to 0.94), p<0.001; wrist-only group: coefficient = 0.59 (95% CI 0.40 to 0.77), p<0.001). Bone oedema score explained 41% of the variation in the progression of TSS (wrist+MCP group), 25% in wrist-only group (Pearson’s r = 0.64 and r = 0.50, respectively). Results were confirmed by sensitivity analyses.

Conclusion: In a randomised controlled trial aiming at remission in patients with early RA, baseline RAMRIS MRI bone oedema score of MCP and wrist joints (and of wrist only) was the strongest independent predictor of radiographic progression in hands, wrists and forefeet after 2 years. MRI synovitis score, MRI erosion score, DAS28, anti-CCP, SE, smoking, age and gender were not independent risk factors.

Trial registration number: NCT00209859.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Duer-Jensen, A, Ejbjerg, B, Albrecht-Beste, E, Vestergaard, A, Dohn, U M., Hetland, M L., Ostergaard, M (2009). Does low-field dedicated extremity MRI (E-MRI) reliably detect bone erosions in rheumatoid arthritis? A comparison of two different E-MRI units and conventional radiography with high-resolution CT scanning. Ann Rheum Dis 68: 1296-1302 [Abstract] [Full Text]  
  • Eshed, I., Feist, E., Althoff, C. E., Hamm, B., Konen, E., Burmester, G.-R., Backhaus, M., Hermann, K.-G. A. (2009). Tenosynovitis of the flexor tendons of the hand detected by MRI: an early indicator of rheumatoid arthritis. Rheumatology (Oxford) 48: 887-891 [Abstract] [Full Text]  
  • Ziswiler, H.-R., Aeberli, D., Villiger, P. M., Moller, B. (2009). High-resolution ultrasound confirms reduced synovial hyperplasia following rituximab treatment in rheumatoid arthritis. Rheumatology (Oxford) 48: 939-943 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs